Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (8298)	5/21/1998 7:53:00 PM
From: Sidney Merle Foster	Read Replies (1) \| Respond to of 23519

FWIW I am a diabetic and have ED. This week I took one 50 mg of Viagra with no effect at all. Two days later I took 2 of the 50 mg of Viagra and 30 min later I was flushed and the blue hue is true. Like you have sun glasses on. At this dosage and with a helpful partner it worked. I will not use Viagra anymore. I have not tried Muse but will. Sid

To: VLAD who wrote (8298)	5/21/1998 7:57:00 PM
From: DaiS	Read Replies (1) \| Respond to of 23519

I am really excited about finding out about all the new ED product developments announced at the meeting. Someone on another thread thread said that Vivus were working on their own pill. And WiseFox on the Yahoo thread said that there was a new muse delivery system in the offing. A small explosive charge in the applicator that sends the pellet further towards the base of the penis (just joking this time? - about the charge, that is, not the new delivery system). Bed time here now. Good-night DaiS

To: VLAD who wrote (8298)	5/21/1998 7:57:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

From a TA perspective, the stock has now formed a nice base in the 9 3/4 to 10 1/2 range. I see no reason for Vivus to go down but many reasons for it to start an uptrend. I have a feeling that international sales will offset some of the losses due to Viagra and once the domestic sales rebound along with international sales the earnings should be good.